BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/17/2023 8:56:22 AM | Browse: 36 | Download: 20
Publication Name |
World Journal of Stem Cells |
Manuscript ID |
87928 |
Country/Territory |
China |
Category |
Transplantation |
Manuscript Type |
Basic Study |
Article Title |
Dissecting molecular mechanisms underlying ferroptosis in human umbilical cord mesenchymal stem cells: Role of cystathionine γ-lyase/hydrogen sulfide pathway
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Bin Hu, Xiang-Xi Zhang, Tao Zhang and Wan-Cheng Yu |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Natural Science Foundation of Shandong Province of China |
ZR2021QH179, ZR2020MH014 |
|
Corresponding Author |
Wan-Cheng Yu, Doctor, MD, Postdoc, Surgeon, Department of Cardiovascular Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No. 324 Jingwu Weiqi Road, Jinan 250062, Shandong Province, China. yuwancheng123@126.com |
Key Words |
Human umbilical cord mesenchymal stem cells; Cystathionine γ-lyase/hydrogen sulfide pathway; Ferroptosis; Pulmonary arterial hypertension; S-sulfhydration |
Core Tip |
Regulation of the cystathionine γ-lyase (CSE)/hydrogen sulfide (H2S) pathway in human umbilical cord mesenchymal stem cells (HUCMSCs) contributes to the inhibition of ferroptosis and improves the suppressive effect of HUCMSCs on vascular remodelling in hypoxia-induced pulmonary arterial hypertension (PAH) mice. Moreover, the protective effect of the CSE/H2S pathway against ferroptosis in HUCMSCs was mediated via S-sulfhydrated Kelch-like ECH-associating protein 1/nuclear factor erythroid 2-related factor 2 signalling. The present study may provide a novel therapeutic avenue for improving the protective capacity of transplanted MSCs in PAH. |
Citation |
Hu B, Zhang XX, Zhang T, Yu WC. Dissecting molecular mechanisms underlying ferroptosis in human umbilical cord mesenchymal stem cells: Role of cystathionine γ-lyase/hydrogen sulfide pathway. World J Stem Cells 2023; 15(11): 1017-1034 |
 |
Received |
|
2023-09-02 14:33 |
 |
Peer-Review Started |
|
2023-09-02 14:34 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2023-10-19 15:08 |
 |
Revised |
|
2023-10-25 15:38 |
 |
Second Decision |
|
2023-11-13 00:54 |
 |
Accepted by Journal Editor-in-Chief |
|
2023-11-15 08:37 |
 |
Accepted by Company Editor-in-Chief |
|
2023-11-17 08:56 |
 |
Articles in Press |
|
2023-11-17 08:56 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2023-11-10 05:47 |
 |
Typeset the Manuscript |
|
2023-11-21 09:05 |
ISSN |
1948-0210 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Assistant Editor |
Assistant Editor |
Science Editor |
Jing-Jie Wang |
Reviewer Code |
03949576, 03712811, 00415501, and 03949576 |
Editorial Director |
|
Journal Chief Editor |
Shengwen Calvin Li |
Company Chief Editor |
Jin-Lei Wang |
Language Editor |
Tian-Qi Wang |
Production Editor |
Xiang-Di Zhang |
Responsible Production Editor |
Xiang-Di Zhang |
Responsible Science Editor |
|
Proofing Editorial Director |
Jin-Lei Wang |
Proofing Editor-in-Chief |
Lian-Sheng Ma |
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345